Today’s Stock Market in 2-Minutes
November 20, 2026
November 20, 2026
November 20, 2026
November 20, 2026
November 20, 2026
Watch the replay of Axe Compute's Second Quarter 2026 earnings conference call, originally held live on Monday, August 17, 2026 at 8:30 a.m. Eastern Time. Christopher Miglino, Chief Executive Officer; Kyle Okamoto, President; and Jeremy Yaukey-Witter, Chief Financial Officer, review the Company's Q2 2026 financial results, recent business developments, and priorities for the second half of 2026. Key highlights discussed on the call: Revenue grew more than 90x sequentially in the Company's first full quarter of compute operations Customer prepayments grew from $0.8 million to $60.8 million, with $17.4 million in operating cash flow in the first half of 2026 The $260 million dedicated cluster of 2,304 NVIDIA B300 GPUs progressed through build, targeted for Q3 2026 go-live Total 2026 signed contracted value now exceeds $3 billion Read the full press release and financial statements on Axe Compute's investor website.
August 17, 2026PALO ALTO, Calif., Aug. 15, 2024 /PRNewswire/ — Mega Matrix Corp. (“MPU” or the “Company”) (NYSE American: MPU), today announced that it launched its Japanese-language short drama “ドS社長と死にゆく奥様の百日戦争” on August 13th at FlexTV. The intense emotional confrontations in the drama are like sharp lancet blades, precisely dissecting the dark sides of the characters’ inner selves. This compels the audience […]
August 15, 2024
November 19, 2026
$4.0 million registered direct offering of common stock, led by existing shareholders and management $2.25 million of Avenue debt satisfied through the issuance of common stock at the same offering price Total debt reduced by $5.25 million, to $12.25 million, saving approximately $0.7 million in interest over 12 months Maturity extended one year to July […]
November 20, 2026
NEW YORK, Nov. 20, 2026 (GLOBE NEWSWIRE) — A simple blood test that can detect cancer before symptoms appear is one of the most compelling developments taking shape in modern medicine. Biotechnology companies are now using artificial intelligence, genomic sequencing and advanced blood analysis to identify biological signals associated with breast and colorectal cancer. These […]
November 20, 2026
November 20, 2026
November 20, 2026
November 20, 2026
November 20, 2026
November 20, 2026
November 20, 2026
November 20, 2026
November 20, 2026